| Primary |
| Depression |
60.0% |
| Contraception |
20.0% |
| Hypothyroidic Goitre |
20.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
21.2% |
| Breast Cancer |
14.2% |
| Depression |
10.6% |
| Drug Use For Unknown Indication |
8.0% |
| Hypothyroidism |
8.0% |
| Foetal Exposure During Pregnancy |
5.3% |
| Bipolar Disorder |
4.4% |
| Hyperphosphataemia |
3.5% |
| Vitamin Supplementation |
3.5% |
| Generalised Anxiety Disorder |
2.7% |
| Myxoedema |
2.7% |
| Anxiety |
1.8% |
| Asthma |
1.8% |
| Dementia |
1.8% |
| Epilepsy |
1.8% |
| Hormone Suppression Therapy |
1.8% |
| Hypocalcaemia |
1.8% |
| Influenza Immunisation |
1.8% |
| Mineral Supplementation |
1.8% |
| Osteoporosis |
1.8% |
|
| Weight Increased |
11.1% |
| Bladder Tamponade |
8.3% |
| Complication Of Pregnancy |
8.3% |
| Atrial Fibrillation |
5.6% |
| Decubitus Ulcer |
5.6% |
| Hemivertebra |
5.6% |
| Hepatic Cancer |
5.6% |
| Thyroid Cancer |
5.6% |
| Tri-iodothyronine Decreased |
5.6% |
| Varicose Vein |
5.6% |
| Visual Disturbance |
5.6% |
| Weight Decreased |
5.6% |
| Death |
2.8% |
| Foetal Death |
2.8% |
| Foetal Exposure During Pregnancy |
2.8% |
| Haemorrhage |
2.8% |
| Infantile Colic |
2.8% |
| Myocardial Infarction |
2.8% |
| Pregnancy |
2.8% |
| Renal Failure |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
15.2% |
| Rheumatoid Arthritis |
10.6% |
| Hypertension |
9.8% |
| Hypothyroidism |
9.2% |
| Osteoporosis |
3.6% |
| Depression |
3.2% |
| Diabetes Mellitus |
2.8% |
| Pain |
2.1% |
| Diffuse Large B-cell Lymphoma |
2.0% |
| Prophylaxis |
2.0% |
| Thyroid Disorder |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Atrial Fibrillation |
1.5% |
| Constipation |
1.3% |
| Premedication |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Schizophrenia |
1.2% |
| Asthma |
1.1% |
| Breast Cancer Metastatic |
1.1% |
|
| Vomiting |
9.9% |
| Death |
8.2% |
| Pneumonia |
8.2% |
| Weight Decreased |
7.2% |
| Renal Failure |
6.5% |
| Sepsis |
5.5% |
| Somnolence |
5.5% |
| Urinary Tract Infection |
5.1% |
| Malaise |
4.5% |
| Pyrexia |
4.5% |
| White Blood Cell Count Decreased |
4.1% |
| Hyponatraemia |
3.8% |
| Pain |
3.8% |
| Thrombocytopenia |
3.8% |
| Nausea |
3.4% |
| Vision Blurred |
3.4% |
| Weight Increased |
3.4% |
| Drug Ineffective |
3.1% |
| Pruritus |
3.1% |
| Syncope |
3.1% |
|
| Interacting |
| Epilepsy |
24.4% |
| Blood Cholesterol Increased |
17.1% |
| Convulsion |
12.2% |
| Hypertension |
12.2% |
| Thyroid Disorder |
12.2% |
| Hypothyroidism |
9.8% |
| Asthma |
4.9% |
| Diarrhoea |
2.4% |
| Hashimoto's Thyroiditis |
2.4% |
| Polyarthritis |
2.4% |
|
| Amnesia |
50.0% |
| Drug Interaction |
20.0% |
| Blood Creatine Phosphokinase Increased |
10.0% |
| Hypothyroidism |
10.0% |
| Therapeutic Response Decreased |
10.0% |
|
